Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-03-12 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于回购注销部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the company's repurchase and cancellation of restricted shares under its 2019 restricted stock incentive plan. It details the number of shares repurchased, prices, legal opinions, board and supervisory committee approvals, and the impact on share capital structure. The content focuses on a specific corporate action related to share repurchase and cancellation, not a full financial report or earnings release. It is not a general regulatory filing or a report publication announcement since it contains substantive details about the transaction. Therefore, the document fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2021-03-12 Chinese
独立董事提名人声明（易兰广）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no report or results, no meeting materials, no voting results, and no mention of any financial or legal proceedings. The document is a declaration related to board/management information, specifically about the nomination of a board member. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a regulatory filing. Hence, the classification is MANG with high confidence.
2021-03-12 Chinese
独立董事提名人声明（王红霞）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no report or results announcement, and no mention of voting results or meeting materials. The content is focused on board/management information, specifically about a director nomination. The document length is short (1636 characters), and it is not an announcement of a report publication or a certification. Therefore, the most appropriate classification is Board/Management Information (MANG).
2021-03-12 Chinese
独立董事提名人声明（颜爱民）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There is no financial data, no report or results announcement, and no mention of voting results or meeting materials. This is a declaration related to board/management changes, specifically about a director nomination. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of voting results.
2021-03-12 Chinese
益丰药房关于召开2021年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2021 first extraordinary general meeting of shareholders (临时股东大会) for the company 益丰大药房连锁股份有限公司. It includes information about the meeting date, voting methods, agenda items (such as election of board members and supervisors), voting instructions, and proxy forms. The document does not contain financial statements or results but focuses on the organization and conduct of a shareholders meeting. This matches the description of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it contains substantive meeting and voting information. Therefore, the correct classification is PSI with high confidence.
2021-03-12 Chinese
益丰药房第三届监事会第二十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of a company. It details the meeting attendance, voting results, and specific agenda items such as election of supervisory board members, remuneration plans, stock repurchase and cancellation, and use of surplus funds. There is no financial data or comprehensive report content, but rather a summary of decisions made by the supervisory board. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies. The document length is short and it is not a full financial report or earnings release. Therefore, the classification is MANG with high confidence.
2021-03-12 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.